Incyte Genomics Reschedules Third Quarter Fiscal 2001 Results Release and Conference Call Palo Alto, CA, October 23, 2001 - Incyte Genomics, Inc. (Nasdaq: INCY), the leading genomic information company, announced today it is rescheduling its third-quarter fiscal year 2001 release of results and management conference call for Thursday, October 25, 2001 at 9:30AM PDT. The release had been scheduled for October 24. The date was changed to avoid scheduling conflicts. Company management will host a conference call on Thursday, October 25, 2001 at 9:30 a.m. PDT to discuss the company's results. The dial-in number for the conference call in the U.S will be (877) 692-2588 and the International number will be (973) 872-3462. A replay of the conference call will be available through October 31, 2001 (12:00 midnight PDT). The replay dial-in number for U.S. and International callers will be (973) 341-3080 and the PIN number access code will be 2914135. Incyte Genomics, Inc. has developed the leading integrated platform of genomic technologies designed to aid in the understanding of the molecular basis of disease. Incyte develops and markets genomic databases and partnership programs, genomic data management software, microarray-based gene expression services, related reagents and services. These products, programs and services assist pharmaceutical and biotechnology researchers with all phases of drug discovery and development including gene discovery, understanding disease pathways, identifying new disease targets and the discovery and correlation of gene sequence variation to disease. In addition, Incyte has the largest portfolio of issued United States patents covering human full-length genes and the proteins they encode and is leveraging its intellectual property position to be a leader in therapeutic discoveries. For more information, visit Incyte's web site at http://www.incyte.com. Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of factors that may cause results to differ, see Incyte's SEC reports, including its Quarterly Report on Form 10- Q for the quarter ended June 30, 2001. Incyte disclaims any intent or obligation to update these forward-looking statements.